MICROPORT NEURO (02172) saw its shares climb more than 5% during the morning session. By the time of writing, the stock was up 3.03%, trading at HK$11.21, with a turnover of HK$1.50 million. The move follows an announcement from MICROPORT that it will terminate the merger with its neuroscience subsidiary. The decision was attributed to MICROPORT NEURO's appointment of an independent non-executive director, after which the parent company, under its accounting policies, determined it could no longer exercise control while maintaining significant influence. The termination of the merger is expected to result in the recognition of a deemed disposal gain from the subsidiary. In a related development, Elon Musk recently stated that his brain-computer interface company, Neuralink, will commence mass production of its devices in 2026, concurrently advancing the full automation of its surgical procedures. Guotai Haitong analysts noted that driven by multiple factors including technological breakthroughs, supportive policies, and capital investment, the brain-computer interface industry is poised for significant growth opportunities. They anticipate a release of demand in downstream markets such as healthcare and consumer lifestyles, painting a promising outlook for the sector.